| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Black Diamond Therapeutics, Inc. (BDTX) has 6 insiders with recent SEC Form 4 filings, including 8 buys and 9 sells. BDTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 93.6K | $287.3K | - | |
| Dir | 37.1K | $114.0K | - | |
| Dir | 30.6K | $93.8K | - | |
| Dir | 30.6K | $93.8K | - | |
| Dir | 30.6K | $93.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | Biotech Growth N V53 | 10% Owner | Sell | 5,784,292 | $2.07 | $11,997,749.13 | -14.2% | +34.9% | +25.0% | |
| Aug 28, 2024 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Sell | 221,600 | $6.32 | $1,400,556.32 | -5.6% | -61.2% | -55.2% | |
| Oct 17, 2023 | Biotech Growth N V53 | 10% Owner | Buy | 400,000 | $2.34 | $934,080.00 | +4.9% | +20.5% | +45.3% | |
| Jul 5, 2023 | Ra Capital Management, L.P.52 | Director | Buy | 935,850 | $5.00 | $4,679,250.00 | +41.1% | -44.4% | -8.0% | |
| Jul 5, 2023 | Behbahani Ali46 | Director | Buy | 1,000,000 | $5.00 | $5,000,000.00 | +29.0% | -44.4% | -8.0% | |
| Jun 30, 2023 | Biotech Growth N V53 | 10% Owner | Buy | 1,000,000 | $5.00 | $5,000,000.00 | +14.0% | -41.4% | -7.7% | |
| Jun 27, 2023 | Epstein David M. | See Remarks | Sell | 25,000 | $6.70 | $167,500.00 | -3.6% | -48.7% | -24.1% | |
| Jun 27, 2023 | Biotech Growth N V53 | 10% Owner | Buy | 1,740,000 | $5.49 | $9,555,036.00 | +32.4% | -48.7% | -24.1% | |
| Dec 22, 2022 | Ni Fang77 | See Remarks | Buy | 56,363 | $1.28 | $72,365.55 | +35.7% | +37.9% | +117.4% | |
| Oct 31, 2022 | Biotech Growth N V53 | 10% Owner | Buy | 99,801 | $2.25 | $224,911.53 | +1.9% | +30.3% | -18.6% |